Quantification of Upper Extremity Hypertonia

Dystonia Clinical Trial

Official title:

Quantification of Upper Extremity Hypertonia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00285870
• Other study ID #: UPPER EXTREMITY HYPERTONIA
• Status: Completed
• Phase: N/A
• First received: January 31, 2006
• Last updated: March 11, 2013
• Start date: January 2006
• Est. completion date: December 2012

Study information

• Verified date: March 2013
• Source: University of Southern California
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

Dr. Sanger and the research team want to learn about upper extremity hypertonia (stiffness) in children and young adults with cerebral palsy. Specifically, they want to learn about ways to measure the stiffness in the joints of hypertonic arms. The information the research team will collect includes any physical exams or computer generated data about your arm movements.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: December 2012
• Est. primary completion date: December 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 4 Years and older

Eligibility

Inclusion Criteria:Dystonia in at least one arm Age 4 to no upper limit

Exclusion Criteria:increased risk of participation botulinum toxin within 6 months

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Dystonia
• Muscle Hypertonia

Locations

Country	Name	City	State
United States	Stanford University School of Medicine	Stanford	California

Sponsors (1)

Lead Sponsor	Collaborator
University of Southern California

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Observation		1 hour	No